← Leaderboards
Milind Singh
Orbis Biosciences, Inc.
$210,328
Attributed
$756,754
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $503.1K · FY2011–12$1M$750K$500K$250K$0
'11
'12
Funding mix
By agency
NIH$756,754 · 3
By mechanism
R43$756,754 · 3
Top collaborators
- Cory Berkland3 shared
- Nathan H Dormer2 shared
- David Dumbauld2 shared
- Maria Flynn1 shared
Most similar at Orbis Biosciences, Inc.
Same institution · by research overlap
- Nathan H Dormer$4,888,977
- David Dumbauld$125,769
- Maria Flynn$258,353
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPrincipal InvestigatorTechnologyDoseParticleControlled ReleasePositioning AttributeSuccessDrug FormulationsAnimalsKineticsKansasMarketingMicrospheresParticle SizeEnsureBaseEncapsulatedIncentivesDosageCharacteristicsEngineeringIn VitroDesign
Grant awards (3)
Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran$287,056
R43 · FY2012 · DC
Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric$216,020
R43 · FY2012 · HD · contact PI
Multi-day Pain Management Therapy with Novel Injectable Formulation$253,678
R43 · FY2011 · DA